Yu Chen

机构：Zhejiang Chinese Medical University, Weifang Medical University, Fujian Medical University, Montefiore Medical Center, Sichuan University, Beijing VDJBio (China), Third Affiliated Hospital of Southern Medical University, West China Hospital of Sichuan University, Second Affiliated Hospital of Guangzhou Medical University, West Africa Vocational Education, Southern Medical University, China Medical University, Guangzhou Medical University · ORCID：0000-0003-4458-4039

发表论文 53 篇 · 总被引 566 次 · h-index 13

代表论文

• KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors (2023 · Nature Communications · 被引 88)
• LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemia (2024 · Haematologica · 被引 13)
• Comprehensive strategies in breast cancer-related lymphedema prevention: insights from a multifaceted program (2024 · Frontiers in Oncology · 被引 13)
• Combining TIGIT blockade with IL‐15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma (2024 · Clinical and Translational Medicine · 被引 9)
• LP-168 (Rocbrutinib), a Novel Covalent and Non-Covalent Next-Generation Inhibitor of Bruton's Tyrosine Kinase: Updates on the Phase 1 Trial and Initial Results of the CLL Gatekeeper Mutation Cohort (2024 · Blood · 被引 8)
• Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population (2024 · Annals of Surgical Oncology · 被引 5)